mRNA vaccine triggers fierce immune response to fight malignant brain tumor
Вставка
- Опубліковано 30 кві 2024
- In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at UF quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor.